Wave life sciences reports fourth quarter and full year 2024 financial results and provides business update

Dosing underway in inlight trial of wve-007 in obesity with clinical data expected in 2h 2025; enrollment complete in first single dose cohort

WVE Ratings Summary

WVE Quant Ranking